Pages that link to "Q36843766"
Jump to navigation
Jump to search
The following pages link to Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells (Q36843766):
Displaying 50 items.
- Small-molecule Bcl-2 antagonists as targeted therapy in oncology (Q24646161) (← links)
- Bcl-2 antagonists: a proof of concept for CLL therapy (Q26823996) (← links)
- Targeting the apoptosis pathway in hematologic malignancies (Q27024422) (← links)
- Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression (Q28485457) (← links)
- Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia (Q30848149) (← links)
- The immunosuppressive effect of gossypol in mice is mediated by inhibition of lymphocyte proliferation and by induction of cell apoptosis (Q33429568) (← links)
- The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells (Q34055891) (← links)
- Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia (Q35022490) (← links)
- Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo (Q35387996) (← links)
- (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis. (Q35582270) (← links)
- AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations (Q36081033) (← links)
- Broad targeting of resistance to apoptosis in cancer. (Q36483749) (← links)
- Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review (Q36541458) (← links)
- Novel targeted treatment strategies for refractory chronic lymphocytic leukaemia (Q36612602) (← links)
- The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2/Akt/FOXO3a signaling. (Q36629469) (← links)
- Selenoprotein R Protects Human Lens Epithelial Cells against D-Galactose-Induced Apoptosis by Regulating Oxidative Stress and Endoplasmic Reticulum Stress (Q36667139) (← links)
- AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance (Q37039117) (← links)
- Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma (Q37163806) (← links)
- Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia (Q37187536) (← links)
- Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation (Q37521403) (← links)
- Gossypol--a polyphenolic compound from cotton plant (Q37625020) (← links)
- Targeting the BCL-2 family in malignancies of germinal centre origin. (Q37634558) (← links)
- Inflammation and survival pathways: chronic lymphocytic leukemia as a model system (Q37778876) (← links)
- Biologic agent activity in chronic lymphocytic leukemia: a framework for future therapies (Q37842484) (← links)
- Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. (Q37910914) (← links)
- Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia (Q37964916) (← links)
- Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia (Q37997623) (← links)
- A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia (Q38061861) (← links)
- Therapeutic potential of gossypol: an overview (Q38145229) (← links)
- Apoptosis inducers in chronic lymphocytic leukemia (Q38187815) (← links)
- Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy (Q38331755) (← links)
- Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies (Q38442515) (← links)
- The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia (Q38766548) (← links)
- Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells. (Q39134027) (← links)
- Natural Bcl-2 inhibitor (-)- gossypol induces protective autophagy via reactive oxygen species-high mobility group box 1 pathway in Burkitt lymphoma (Q39196767) (← links)
- Defective autophagy in multidrug resistant cells may lead to growth inhibition by BH3-mimetic gossypol (Q39223417) (← links)
- Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species (Q39310631) (← links)
- Mcl-1 Phosphorylation defines ABT-737 resistance that can be overcome by increased NOXA expression in leukemic B cells (Q39360515) (← links)
- Bax345/BLyS: A novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin (Q39386127) (← links)
- Autophagy in Cancer Therapy (Q39412865) (← links)
- A Novel Water-Soluble Gossypol Derivative Increases Chemotherapeutic Sensitivity and Promotes Growth Inhibition in Colon Cancer (Q39671583) (← links)
- The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy (Q39694585) (← links)
- ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway (Q39809859) (← links)
- Cytosolic Ca2 shifts as early markers of cytotoxicity (Q42583711) (← links)
- Bax and Bak are required for apogossypolone, a BH3-mimetic, induced apoptosis in chronic lymphocytic leukemia cells (Q42773124) (← links)
- Different forms of cell death induced by putative BCL2 inhibitors. (Q43763736) (← links)
- Gossypol as undesirable substance in animal feed - Scientific Opinion of the Panel on Contaminants in the Food Chain (Q47146208) (← links)
- Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cells (Q50950235) (← links)
- Gossypol toxicity from cottonseed products. (Q51136239) (← links)
- Personalizing treatment for chronic lymphocytic leukemia. (Q54612791) (← links)